1. Home
  2. VYGR vs QIPT Comparison

VYGR vs QIPT Comparison

Compare VYGR & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.79

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Logo Quipt Home Medical Corp.

QIPT

Quipt Home Medical Corp.

HOLD

Current Price

$3.61

Market Cap

157.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
QIPT
Founded
2013
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
194.0M
157.2M
IPO Year
2015
2012

Fundamental Metrics

Financial Performance
Metric
VYGR
QIPT
Price
$3.79
$3.61
Analyst Decision
Strong Buy
Buy
Analyst Count
6
2
Target Price
$17.00
$3.83
AVG Volume (30 Days)
527.4K
356.2K
Earning Date
01-01-0001
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,135,000.00
$245,359,000.00
Revenue This Year
N/A
$28.30
Revenue Next Year
$71.77
$1.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$1.37
52 Week High
$5.55
$3.63

Technical Indicators

Market Signals
Indicator
VYGR
QIPT
Relative Strength Index (RSI) 47.48 71.10
Support Level $2.79 $3.55
Resistance Level $3.73 N/A
Average True Range (ATR) 0.21 0.02
MACD 0.00 -0.01
Stochastic Oscillator 54.65 61.54

Price Performance

Historical Comparison
VYGR
QIPT

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About QIPT Quipt Home Medical Corp.

Quipt Home Medical Corp is a provider of durable medical equipment (DME) and home medical equipment (HME) in the United States. The Company specializes in delivering in-home treatments for the management of chronic conditions, with a primary focus on respiratory diseases, and supports patients with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. Its products and services include Sleep Apnea and PAP treatment, home medical equipment, home ventilation, and custom mobility solutions. The Company operates in a single business segment, comprising the sale and rental of medical equipment and related devices, and serves patients across 27 states in the United States.

Share on Social Networks: